| 000 | 01386 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250515133018.0 | ||
| 264 | 0 | _c20081113 | |
| 008 | 200811s 0 0 eng d | ||
| 022 | _a0378-1097 | ||
| 024 | 7 |
_a10.1111/j.1574-6968.2008.01308.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBecker, Stephen C | |
| 245 | 0 | 0 |
_aThe phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA. _h[electronic resource] |
| 260 |
_bFEMS microbiology letters _cOct 2008 |
||
| 300 |
_a185-91 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xisolation & purification |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aEndopeptidases _xgenetics |
| 650 | 0 | 4 |
_aEscherichia coli _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLysostaphin _xpharmacology |
| 650 | 0 | 4 | _aMethicillin Resistance |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xgenetics |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xdrug therapy |
| 650 | 0 | 4 |
_aStaphylococcus Phages _xmetabolism |
| 650 | 0 | 4 |
_aStaphylococcus aureus _xdrug effects |
| 650 | 0 | 4 |
_aViral Proteins _xgenetics |
| 700 | 1 | _aFoster-Frey, Juli | |
| 700 | 1 | _aDonovan, David M | |
| 773 | 0 |
_tFEMS microbiology letters _gvol. 287 _gno. 2 _gp. 185-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1574-6968.2008.01308.x _zAvailable from publisher's website |
| 999 |
_c18192949 _d18192949 |
||